학술논문

Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial
Document Type
Article
Source
In Lancet Oncology February 2014 15(2):191-200
Subject
Primary Research
Articles
Language
ISSN
1470-2045